stockrowDianthus Therapeutics, Inc. (DNTH) vs Scholar Rock Holding Corporation (SRRK)
- Dianthus Therapeutics, Inc. DNTH 86.43 +4.12%
- Scholar Rock Holding Corporation SRRK 46.94 +3.16%
Dianthus Therapeutics, Inc. and Scholar Rock Holding Corporation are both Biotechnology companies. Scholar Rock Holding Corporation is the larger, with a market value of $5.5B against $4.6B — 1.2× the size. Scholar Rock Holding Corporation grew revenue faster over the last twelve months: 213.7% against −11.7%. Scholar Rock Holding Corporation has the higher net margin (0.00% vs −7,436.5%) and the higher return on invested capital (0.00% vs −36.6%). Across the 17 metrics below, Scholar Rock Holding Corporation leads on 9 and Dianthus Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | DNTH | SRRK | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 68.51% |
| Operating margin | (8,683.89%) | 0.00% | 0.00% |
| Net margin | (7,436.50%) | 0.00% | 0.00% |
| Free cash flow margin | (6,469.87%) | 0.00% | 0.00% |
| Return on equity | (22.61%) | (167.77%) | (51.96%) |
| Return on assets | (21.81%) | (94.63%) | (46.06%) |
| Return on invested capital | (36.55%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack